This forum will showcase the results of clinical trials and other important research findings that were completed and submitted for consideration after the general deadline for submission of abstracts.
This year's Late-Breaking Science Forum will include presentation of scientific discovery in the areas of Prostate Cancer, Neurogenic Bladder, Chronic Pelvic Pain Syndrome and Overactive Bladder.
Further Analyses from the REDUCE Prostate Cancer Risk Reduction Trial - Gerald L. Andriole Jr., MD [ View Abstract ]
A Phase 2 Study - Tengion Autologous Neo-Bladder Augment™ (NBA) for Augmentation Cystoplasty in Subjects with Neurogenic Bladder Secondary to Spina Bifida - David B. Joseph, MD [ View Abstract ]
Clinical Phenotyping of Urologic Chronic Pelvic Pain Syndromes (UCPPS): Validation of the "Snowflake Hypothesis" - J. Curtis Nickel, MD [ View Abstract ]
Effects of Darifenacin and Tolterodine on Heart Rate in Subjects ≥50 years of Age: Results of a Randomized, Double-Blind, 3-way Crossover Study - Brian Olshansky, MD [ View Abstract ]
The Use of a Novel Thermosensitive Polymer (BackStop™) to Prevent Proximal Ureteric Stone Retropulsion During Intracorporeal Lithotripsy: A Prospective Randomized Controlled Clinical Trial - Abhay Rane, MD [ View Abstract ]
High Power Diode 980 Laser Vaporisation of the Prostate: Preliminary Results of the "LIFE" Procedure - Kamil Cam, MD [ View Abstract ]
Tolerability of Solifenacin in Comparison with Oxybutynin Immediate Release in Patients with Overactive Bladder: Results of the VECTOR Study - Sender Herschorn, MD [ View Abstract ]
Botulinum Toxin A (BOTOX®) Demonstrates Dose-Dependent Improvements in Health-Related Quality-Of-Life Measures in Idiopathic Overactive Bladder - Clare Fowler, MD [ View Abstract ]
A randomized, double-blind, placebo-controlled, multi-center, phase III trial of sipuleucel-T in men with metastatic, androgen independent prostatic adenocarcinoma (AIPC) - PF Schellhammer, C Higano, ER Berger, N Shore, E Small, D Penson, A Ferrari, R Sims, L Yuh, M Frohlich, P Kantoff for the IMPACT Study Investigators [ View Abstract ]
